Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lingwen Ding"'
Autor:
Lingwen Ding, Jiawen Guo, Yajun Yang, Yanhui Lu, Xin Xie, Zhongxian Lu, Shuping Wang, Hongxing Xu
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Nutrition is a limiting feature of species evolution. The differences in nutritional requirements are the evolutionary result of differential adaptations to environmental changes, explaining differences in their ecological traits. Cnaphalocr
Externí odkaz:
https://doaj.org/article/7b1946eeed57492ba80b5905674bdbfc
Autor:
Rong Wang, Yuanyuan Mi, Jiang Ni, Yang Wang, Lingwen Ding, Xuebin Ran, Qiaoyang Sun, Soo Yong Tan, H Phillip Koeffler, Ninghan Feng, Yong Q Chen
Publikováno v:
Advanced Science, Vol 11, Iss 9, Pp n/a-n/a (2024)
Abstract Treatment of castration‐resistant prostate cancer (CRPC) is a long‐standing clinical challenge. Traditionally, CRPC drugs work by either reducing dihydrotestosterone biosynthesis or blocking androgen receptor (AR) signaling. Here it is d
Externí odkaz:
https://doaj.org/article/598b79c327864817bc781b8e5e7ce0ef
Autor:
Xi Ren, Bin Zhang, Jia Li, Thamizhanban Manoharan, Beijia Liu, Yangyang Song, Shuye Tian, Kar-Tong Tan, Lingwen Ding, Ying Li, Omer An, Ming Li, Chan-Shuo Wu, Yang Liu, Boon Heng Dennis Teo, Sze Jing Tang, Jinhua Lu, Yuhui Hu, Wei Chen, Leilei Chen, Gloryn Chia, Henry Yang
Tumor-specific neoantigens have emerged as a promising source for cancer immunotherapy. These tumor-specific neoantigens could arise from somatic mutations, aberrant splicing and RNA editing. Since intronic polyadenylation has similar potential as mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11468b1a6fdbf7c509e96410f5ada743
https://doi.org/10.21203/rs.3.rs-1537870/v1
https://doi.org/10.21203/rs.3.rs-1537870/v1
Autor:
Pei Huang, Lingsheng Jiang, Hui Pan, Lingwen Ding, Bo Zhou, Mengyao Zhao, Jianhua Zou, Benhao Li, Meiwei Qi, Hongzhang Deng, Yongfeng Zhou, Xiaoyuan Chen
Publikováno v:
Advanced Materials. 35:2207471
Among the few available mRNA delivery vehicles, lipid nanoparticle (LNP) is the most clinically advanced one but requires cumbersome four components and suffers from inflammation-related side effects which should be minimized for safety. Yet, a certa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de74d61d3682efe919c50cf983d30b9d
https://doi.org/10.1002/adma.202207471
https://doi.org/10.1002/adma.202207471
Autor:
Lingwen Ding, Qiaoyang Sun, Kar-Tong Tan, Wenwen Chien, Anand Mayakonda, Dechen Lin, Xinyi Loh, Jinfen Xiao, Manja Meggendorfer, Tamara Alpermann, Manoj Garg, Su-Lin Lim, Vikas Madan, Norimichi Hattori, Yasunobu Nagata, Satoru Miyano, Allen Yeoh Eng Juh, Hsin-An Hou, Yan-Yi Jiang, Sumiko Takao, Li-Zhen Liu, Siew-Zhuan Tan, Michael Lill, Mutsumi Hayashi, Akitoshi Kinoshita, Hagop M. Kantarjian, Steven M. Kornblau, Seishi Ogawa, Torsten Haferlach, Henry Yang, H. Phillip Koeffler
Publikováno v:
Cancer Research. 77:2450-2450
In this study, we performed whole-exome and targeted sequencing on 85 MLL-PTD AML patients. These AMLs have oncogenic tandem duplication of the MLL gene. At least one well-known oncogenic driver mutation was identified in over 90% of the MLL-PTD pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7431e9ba5ee5cceb675f344b64869792
https://doi.org/10.1158/1538-7445.am2017-2450
https://doi.org/10.1158/1538-7445.am2017-2450